Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy

Tumor Biology ◽  
2015 ◽  
Vol 37 (4) ◽  
pp. 4873-4881 ◽  
Author(s):  
Shiwei Liu ◽  
Xuening Duan ◽  
Ling Xu ◽  
Jingming Ye ◽  
Yuanjia Cheng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Therapy ◽  
Pathological Complete Response ◽  
Complete Response ◽  
Event Free Survival ◽  
Her2 Positive ◽  
Free Survival ◽  
Her2 Positive Breast Cancer ◽  
Gli1 Expression ◽  
Positive Breast Cancer

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer

2012 ◽  
Vol 139 (3) ◽  
pp. 491-498 ◽  
Author(s):  
Axel Muendlein ◽  
Alois H. Lang ◽  
Simone Geller-Rhomberg ◽  
Thomas Winder ◽  
Klaus Gasser ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Genetic Variant ◽  
Event Free Survival ◽  
Common Genetic Variant ◽  
Her2 Positive ◽  
Free Survival ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis

2020 ◽  
Vol 84 ◽  
pp. 101965 ◽  
Author(s):  
Francesco Schettini ◽  
Tomás Pascual ◽  
Benedetta Conte ◽  
Nuria Chic ◽  
Fara Brasó-Maristany ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Pathological Complete Response ◽  
Meta Analysis ◽  
Complete Response ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document